On October 6, 2015 Cancer Research UK reported taht it has received a major donation of £100,000 from Elsevier (link is external), a world-leading provider of scientific, technical and medical information products and services, towards its fundraising campaign to help build the Francis Crick Institute, a pioneering medical research facility in the heart of London (Press release, Cancer Research UK, OCT 6, 2015, View Source [SID:1234507653]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
"This donation from Elsevier, a world-leading research information company, marks a significant step in our effort to bring together a multitude of stakeholders united by a common goal to tackle the hardest problems in biomedical research today." – Harpal Kumar, Cancer Research UK
The new state-of-the-art biomedical research institute, currently being built in King’s Cross and due to open in 2016, will see more than 1,200 scientists collaborating to discover the biology underlying major human diseases – cancer, heart disease, lung disease, infectious diseases such as HIV and malaria and many more.
Elsevier’s donation towards the campaign will help fund Cancer Research UK’s contribution towards the Crick’s development, helping to establish this significant and distinctive new biomedical research institute. The Crick aims to make the next leap forward in biomedical research by "translating the latest laboratory discoveries into the next generation of medical breakthroughs", a mission strongly shared by Elsevier.
Harpal Kumar, chief executive of Cancer Research UK, said: "This donation from Elsevier, a world-leading research information company, marks a significant step in our effort to bring together a multitude of stakeholders united by a common goal to tackle the hardest problems in biomedical research today."
Ron Mobed, chief executive at Elsevier, said: "Elsevier is interested not just in the publication of research findings, but in the utility of those findings in the practical implementation of new research and in policy decision making. The Crick’s commitment to excellence, emphasis on multidisciplinary research, focus on young and emerging talent and new ways of collaborating are very much aligned with our mission. It represents the future of how science could be applied to benefit society and is an endeavor we very much want to support."
The Francis Crick Institute is a collaboration between six of the world’s leading medical research organisations: Cancer Research UK, The Medical Research Council, The Wellcome Trust, UCL (University College London), King’s College London and Imperial College London. With a unique multidisciplinary approach to unravelling the mysteries behind major diseases and dedicated to research excellence, the institute will have the scale, vision and expertise to tackle challenging scientific questions underpinning health and disease.